The purpose of this study is to evaluate the effect of food intake in bioavailability (BA) of
the combination Glimepiride/ extended release Metformin GLI/METXR (4/850mg) in healthy
Methods: A prospective, longitudinal, open label, non randomized study, was performed. A
single oral dose of GLI/METXR (4/850 mg) was administered to 24 health Mexican volunteers 30
min after a high fat meal.